Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03850899 · ClinicalTrials.gov registry record
Alcoholic Hepatitis Network Observational Study
A clinical trial of Alcoholic Hepatitis, sponsored by Indiana University.
- Completed
- Registry status
- 1,133
- Enrollment target
- 9
- Study locations
NCT03850899 is a study of Alcoholic Hepatitis that has completed, run by Indiana University. The registered enrollment target is 1,133 participants, above the 75-participant average among 5 other Alcoholic Hepatitis trials with a reported enrollment target (1411% higher). The trial reports 9 study locations across 8 states.
The verdict
NCT03850899, a study of Alcoholic Hepatitis, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 1,133 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of this research study is to create a clinical database and bio-repository. To do this, we will obtain blood, urine, saliva, and stool samples (e.g., biological samples) and personal health information from you to use in future research studies related to alcoholic hepatitis or other diseases. Part of your blood sample will be used to extract your DNA. DNA is the genetic material that gives us unique characteristics. We are doing this research study because we are trying to find out more about how and why illnesses related to alcoholic hepatitis or other diseases occur in people. To do this, we will study the biological samples and personal health information from healthy and sick people. A "biological sample" is usually blood, but can be any body fluid. "Personal Health Information" includes such items as your name, age, gender, race, and/or your medical information. It can also include data from measurements and tests that you had while participating in another research study or that were done during the course of your regular medical care or doctor visits.
Conditions Studied
Study Locations (9)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
- University Of Massachusetts - Worcester
Indiana
- IU School of Medicine - Indianapolis
Kentucky
- University of Louisville - Louisville
Minnesota
- Mayo Clinic - Rochester
Ohio
- Cleveland Clinic - Cleveland
Pennsylvania
- University of Pittsburgh - Pittsburgh
Texas
- University of Texas Southwestern Medical School - Dallas
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,133 participants |
| Start Date | 2019-04-17 |
| Est. Completion | 2024-06-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03850899
The ClinicalTrials.gov registry entry for NCT03850899 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,133 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 75-participant average among 5 other Alcoholic Hepatitis trials with a reported enrollment target (1411% higher). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alcoholic Hepatitis appearing as the primary indexed condition, and to 0 interventions.
NCT03850899 reports 9 study locations spanning 8 distinct geographic areas - top geographies include Massachusetts, Indiana, Kentucky.
Frequently Asked Questions
What is clinical trial NCT03850899 about?
NCT03850899 is a clinical study titled "Alcoholic Hepatitis Network Observational Study". The purpose of this research study is to create a clinical database and bio-repository. To do this, we will obtain blood, urine, saliva, and stool samples (e.g., biological samples) and personal health information from you to use in future research studies related to alcoholic hepatitis or other dis...
What is the current status of trial NCT03850899?
This trial is currently completed. The enrollment target is 1,133 participants. The study started on 2019-04-17. Estimated completion is 2024-06-21.
What conditions does trial NCT03850899 study?
This clinical trial studies the following conditions: Alcoholic Hepatitis.
Who is sponsoring clinical trial NCT03850899?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03850899 being conducted?
This trial has 9 study locations across Indiana, Kentucky, Massachusetts, Minnesota, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcoholic Hepatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH
RECRUITING · NA
-
Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis
RECRUITING · Phase 1
-
Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis
RECRUITING
-
HA35 Moderate Alcoholic Hepatitis (AH) Study
RECRUITING · Early Phase 1
-
Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.